Provided by Tiger Trade Technology Pte. Ltd.

Enveric Biosciences

1.43
+0.04002.88%
Volume:89.15K
Turnover:124.77K
Market Cap:6.40M
PE:-0.19
High:1.44
Open:1.40
Low:1.38
Close:1.39
52wk High:17.64
52wk Low:1.25
Shares:4.48M
Float Shares:4.34M
Volume Ratio:0.40
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4858
EPS(LYR):-36.2437
ROE:-170.04%
ROA:-87.34%
PB:0.79
PE(LYR):-0.04

Loading ...

Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis for Lead Neuroplastogen Candidate Eb-003

THOMSON REUTERS
·
May 19

Enveric Biosciences Inc - Eb-003 Shows No Photoreactive Potential in Preclinical Analysis

THOMSON REUTERS
·
May 19

Enveric Biosciences reports Q1 EPS ($1.08) vs. ($14.58) last year

TIPRANKS
·
May 15

Enveric Biosciences Q1 EPS $(1.08) Up From $(14.64) YoY

Benzinga Earnings
·
May 15

Enveric net loss narrows to $1.6 million in Q1 FY26; loss per share improves to $1.08

Reuters
·
May 15

Enveric Biosciences Q1 EPS USD -1.08

THOMSON REUTERS
·
May 15

Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026

Dow Jones
·
May 15

Enveric Biosciences wins new US patent covering psychiatric disorder treatment methods

Reuters
·
May 13

Enveric Biosciences highlights preclinical data for EB-003

TIPRANKS
·
May 05

BRIEF-Enveric Biosciences Inc - Reports Positive Preclinical Results For Eb-003 In Ptsd Model

Reuters
·
May 05

Enveric Biosciences Inc - Reports Positive Preclinical Results for Eb-003 in Ptsd Model

THOMSON REUTERS
·
May 05

Enveric Biosciences Corrects Reverse Stock Split Proxy Disclosure

TIPRANKS
·
May 01

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM

Reuters
·
Apr 30

Lakewood-Amedex Biotherapeutics names Enveric CEO Joseph Tucker to board

Reuters
·
Apr 29

What's Going On With Enveric Biosciences Stock On Friday?

Benzinga
·
Apr 25

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:48 AM

Reuters
·
Apr 24

BUZZ-Compass Pathways rises after FDA fast-tracks psychedelic drug research

Reuters
·
Apr 24

Enveric Biosciences up 3%, U.S.‑Listed Shares of Cybin Rise 4.5%

THOMSON REUTERS
·
Apr 24

Definium Therapeutics Adds 0.4%, Compass Pathways Rises 5.5%

THOMSON REUTERS
·
Apr 24

Psychedelic Drug Developers Rise After US FDA Moves to Fast-Track Drugs After Trump Order

THOMSON REUTERS
·
Apr 24